Tim Müller Selected Research

ST 679

9/2018	The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy.
1/2018	The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tim Müller Research Topics

Disease

6	Neoplasms (Cancer) 03/2022 - 08/2017
3	Renal Cell Carcinoma (Grawitz Tumor) 02/2019 - 01/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2018 - 12/2017
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 08/2017
1	Endometrial Neoplasms (Endometrial Cancer) 03/2022
1	Carcinogenesis 02/2019
1	Neoplasm Metastasis (Metastasis) 09/2018
1	Papillomavirus Infections 01/2018
1	Glioma (Gliomas) 08/2012
1	Starvation 12/2006

Drug/Important Bio-Agent (IBA)

4	Mediator ComplexIBA 09/2018 - 12/2017
3	Proteins (Proteins, Gene)FDA Link 02/2019 - 08/2012
2	ST 679IBA 09/2018 - 01/2018
2	Messenger RNA (mRNA)IBA 06/2018 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2018 - 12/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2022
1	Estrogen ReceptorsIBA 03/2022
1	Immune Checkpoint InhibitorsIBA 03/2022
1	karyopherin alpha 2IBA 02/2019
1	Indicators and Reagents (Reagents)IBA 02/2019
1	Karyopherins (Importin)IBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 08/2017
1	Programmed Cell Death 1 ReceptorIBA 08/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 08/2012
1	5-hydroxymethylcytosineIBA 08/2012
1	5-Methylcytosine (5 Methylcytosine)IBA 08/2012
1	NitrogenIBA 12/2006

Therapy/Procedure

2	Therapeutics 03/2022 - 08/2017
1	Immunotherapy 03/2022